Phase 3 ARISE trial of solengepras, a potential first-in-class non-dopaminergic therapy, is fully enrolled and topline data ...
Long before the telltale signs of Parkinson's disease appear, including tremors and muscle stiffness, there are other, more ...
CAMBRIDGE, MA, UNITED STATES, May 13, 2026 /EINPresswire.com/ -- Violet Therapeutics (“Violet”), a biotechnology ...
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β ...
In a recent review posted to the medRxiv* preprint server, scientists explore the utility of machine learning methods in the field of neurodegenerative disease diagnosis, prognosis, and treatment ...
A review article published in the journal Nature Communications provides a detailed overview of recent developments in microfluidic chip models for neurodegenerative diseases. Recent advancements in ...
Please provide your email address to receive an email when new articles are posted on . Higher rates of neurodegenerative disease were linked to “central obesity” and “arm-dominant fat distribution.” ...
Neurodegenerative diseases are characterized by the deposition of clumped proteins in the brain and progressive neuronal cell death. Although the causal link between protein aggregates and ...